STOCK TITAN

Armistice Capital (NASDAQ: CRIS) reports 4.99% ownership of Curis

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Armistice Capital, LLC and Steven Boyd filed Amendment No. 3 to a Schedule 13G/A reporting beneficial ownership of 679,033 shares of Curis, Inc. common stock, representing 4.99% of the class. The filing states Armistice Capital is the investment manager of Armistice Capital Master Fund Ltd., which is the direct holder, and that voting and dispositive power are exercised jointly through the Investment Management Agreement. The filing is signed by Steven Boyd as managing member and is dated May 15, 2026.

Positive

  • None.

Negative

  • None.

Insights

Armistice reports a sub-5% passive stake via a managed fund.

Armistice Capital discloses beneficial ownership of 679,033 shares (4.99%), held directly by Armistice Capital Master Fund Ltd. and managed under an Investment Management Agreement. The filing classifies the position as ownership of 5 percent or less of the class.

The statement clarifies voting and dispositive power are exercised by Armistice Capital under the management agreement and that the Master Fund disclaims direct beneficial ownership attributable to its lack of voting/dispositive rights. Subsequent filings would show any material changes to percentage ownership.

The amendment is a routine Schedule 13G/A disclosure with joint-filing language.

The document includes a joint filing statement pursuant to Rule 13d-1(k), attributing responsibility for amendments to the Reporting Persons. It reiterates address, CUSIP 231269309, and the issuer's principal office address in Lexington, MA.

Because the position is reported at 4.99%, the filing aligns with passive/beneficial ownership disclosure conventions under Rule 13G; no change-of-control or activist intent is stated in this excerpt.

Shares beneficially owned 679,033 shares Amount beneficially owned per Item 4(a)
Percent of class 4.99% Percent of class per Item 4(b)
CUSIP 231269309 CUSIP for Curis common stock listed on cover
Filing date / signature date May 15, 2026 Signature date for the amendment
Issuer address 128 Spring Street, Lexington, MA Principal executive offices per Item 1(b)
Schedule 13G/A regulatory
"Amendment No. 3 to Schedule 13G/A reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Investment Management Agreement financial
"Armistice Capital exercises voting and investment power under an Investment Management Agreement"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.
Beneficial ownership regulatory
"Amount beneficially owned: 679,033 and percent of class: 4.99%"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.





231269309

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Armistice Capital, LLC
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd - Managing Member
Date:05/15/2026
Steven Boyd
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd
Date:05/15/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: May 15, 2026 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd

FAQ

What stake does Armistice Capital report in Curis (CRIS)?

Armistice Capital reports beneficial ownership of 679,033 shares, representing 4.99% of Curis common stock. The shares are held directly by Armistice Capital Master Fund Ltd., with Armistice Capital exercising voting and dispositive power under an Investment Management Agreement.

Who is the reporting person on the Schedule 13G/A for CRIS?

The filing lists Armistice Capital, LLC and Steven Boyd as the Reporting Persons. Mr. Boyd is identified as the managing member of Armistice Capital and signed the joint filing dated May 15, 2026.

Does the filing indicate Armistice is an active owner or passive investor?

The amendment is filed under Schedule 13G/A for holdings of 5% or less and contains language consistent with passive reporting. It does not state activist intent or plans to influence control of the issuer in the provided excerpt.

How is beneficial ownership attributed between the Master Fund and Armistice?

The Master Fund is the direct holder of the shares; Armistice Capital is the investment manager and exercises voting and investment power under an Investment Management Agreement, which is the basis for Armistice's beneficial ownership reporting.